Table 2. P/R treatment of HCV infection and SVR rate in the hospital-based population study, 2013–2015.

	HCV treatment		SVR rate
Characteristic	n/N	%	n/N	%	p-value
All	434/947	46	272/370	74
Sex					>0.05
Male	203/461	44	120/172	70
Female	231/486	48	152/198	77
Age, y					<0.01
15–24	12/19	63	8/9	89
25–34	98/195	50	74/88	84
35–44	166/335	50	103/138	75
45–54	96/231	42	58/84	69
55–64	47/100	47	21/37	57
≥65	15/67	22	8/14	57

Abbreviations: HCV, hepatitis C virus; P/R, pegylated-interferon plus ribavirin; SVR, sustained virologic response.